[1]
Amir Mohamed Abdelhamid, Rania Ramadan Abdelaziz, Hoda Atef and Hatem Abdelrahman Ali Salem 2017. The potential role of sitagliptin as an oral treatment regimen for type I diabetes mellitus. World Journal of Pharmaceutical Sciences. 5, 6 (May 2017), 213–225.